No results for ‘’
Norris Medicines Ltd
₹15.60
(0%)
Wed, 26 Aug 2026, 03:33 am
Health Technology
Pharmaceuticals: Major
24.5KNorris Medicines Enterprise Value (EV)
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Norris Medicines Ltd Enterprise Value
The Norris Medicines Ltd Enterprise Value is a key financial metric used by investors to evaluate Norris Medicines Ltd's valuation, profitability, and overall financial performance. Tracking the Norris Medicines Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Norris Medicines Ltd (NSE: , BSE: 524414) is currently trading at ₹15.60, with a market capitalization of ₹0. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Norris Medicines Ltd Enterprise Value is essential for fundamental analysis.
Norris Medicines Ltd Enterprise Value Current Value
The current Norris Medicines Ltd Enterprise Value stands at 0.
The Norris Medicines Ltd Enterprise Value remains stable, indicating consistent financial performance.
Norris Medicines Ltd Enterprise Value Historical Trend
The Norris Medicines Ltd Enterprise Value has shown the following historical trend:
The decline in Norris Medicines Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Norris Medicines Ltd Enterprise Value Indicates for Investors
The Norris Medicines Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Norris Medicines Ltd.
Norris Medicines Ltd Enterprise Value Analysis Summary
The Norris Medicines Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Norris Medicines Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Norris Medicines Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.